Skip to main content
Clinical Trials/NCT02089178
NCT02089178
Terminated
Not Applicable

Comparison of the Effect of Total Intravenous Anesthesia and Inhalation Anesthesia on Cancer Cell Cytotoxicity, Micrometastasis and Recurrence of Tumor in Patients Undergoing Breast Tumor Resection

Yonsei University1 site in 1 country48 target enrollmentFebruary 2014

Overview

Phase
Not Applicable
Intervention
intravenous anesthesia
Conditions
Breast Cancer
Sponsor
Yonsei University
Enrollment
48
Locations
1
Primary Endpoint
number of NK cell
Status
Terminated
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to compare the effect of total intravenous anesthesia and inhalation anesthesia on cancer cell cytotoxicity, micrometastasis and recurrence of tumor in patients undergoing breast tumor resection. Using propofol-remifentanil in total intravenous anesthesia group and sevoflurane -remifentanil in inhalation anesthesia group.

Registry
clinicaltrials.gov
Start Date
February 2014
End Date
December 30, 2014
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patient between 20 and 65 of age with ASA physical status Ⅰ-Ⅲ
  • breast cancer patients with no sign of local invasion (adjacent organs) and distant metastasis revealed by imaging studies
  • surgery performed by the same surgical team

Exclusion Criteria

  • ASA physical status Ⅳ
  • hepatic and renal impairment
  • diabetes or other endocrine disorders
  • body mass index \> 35 kg/m2
  • immune disorders or immunosuppressive therapy
  • steroid treatment in the last 6 months
  • inflammation

Arms & Interventions

intravenous

the total intravenous anesthesia group

Intervention: intravenous anesthesia

intravenous

the total intravenous anesthesia group

Intervention: propofol-remifentanil

inhalation

the inhalation anesthesia group

Intervention: inhalation anesthesia

inhalation

the inhalation anesthesia group

Intervention: sevoflurane-remifentanil

Outcomes

Primary Outcomes

number of NK cell

Time Frame: at 24 hour after surgery.

comparison of the effect of total intravenous anesthesia and inhalation anesthesia on cancer cell cytotoxicity

Study Sites (1)

Loading locations...

Similar Trials